Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis

By sjmartinez • May 23, 2025

Li B, Elsten-Brown J, Li M, Zhu E, Li Z, Chen Y, Kang E, Ma F, Chiang J, Li YR, Zhu Y, Huang J, Fung A, Scarborough Q, Cadd R, Zhou JJ, Chin AI, Pellegrini M, Yang L. Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis. Cell. 2025 May 20:S0092-8674(25)00502-1. doi: 10.1016/j.cell.2025.04.032. Epub ahead of print. PMID: 40403728.

Tags: antidepressants, cancer immunotherapy, Cardiology/Epi, Dermatology, immune checkpoint, intratumoral serotonin axis, PD-1 blockade, Publications, serotonin, serotonin transporter, SSRIs, T cell antitumor immunity, tumor microenvironment, Veterans Administration

Comparative effectiveness of sodium-glucose cotransporter 2 inhibitors along with colchicine versus colchicine alone among coronary artery disease and type 2 diabetes patients

Jaiswal V, Hanif M, Kumar D, Mashkoor Y, Kumar T, Ahmed R, Mattumpuram J, Qamar A, Fonarow GC, Lavie CJ. Comparative effectiveness of sodium-glucose cotransporter[...]

Transgenic mice overexpressing Pitx2 in the atria develop tachycardia-bradycardia syndrome

Baba S, Shinjo S, Seya D, Bochimoto H, Akaike T, Nakano A, Minamisawa S. Transgenic mice overexpressing Pitx2 in the atria develop tachycardia-bradycardia syndrome. PLoS[...]

Predicting risk of cardiovascular events (PREVENT) score accuracy among people with HIV in the multicenter CNICS cohort

Durstenfeld MS, Nance RM, Jones R, Abelman R, Hoffmann AP, Burkholder G, Hsue PY, Longenecker CT, Hunt PW, Saag MS, Delaney JAC, Feinstein MJ, Crane[...]